Guest guest Posted October 27, 2006 Report Share Posted October 27, 2006 > NANOTECHNOLOGY, AGRICULTURAL RESEARCH, MEDICAL, FOOD SAFETY AND RISK > ASSESSMENT > * Four New NIH Nanomedicine Development Centers (NDCs) Announced - On > October 27, the HHS National Institutes of Health issued a news release, > titled " NIH Completes Formation of National Network of Namomedicine > Centers” which states in part the " ... final four NDCs were funded this > year. NIH funded four NDCs last year ... The final four NDCs are located > at: Georgia Institute of Technology in Atlanta; Purdue University in > Lafayette, Indiana; University of California at Los Angeles; [and] > University of California Lawrence Berkeley National Laboratory ... The > four NDCs funded last year are located at ... Baylor College of Medicine > in Houston; University of Illinois Urbana-Champaign; University of > California at San Francisco; [and] Columbia University, New York > Morningside ... [The] NDCs are staffed by multidisciplinary scientific > teams, including biologists, physicians, chemists, physicists, > mathematicians, engineers, and computer scientists. In addition to > conducting research into the physical properties of structures inside > cells to determine how biology's molecular machines are built, these > teams will begin training the next generation of students in this > emerging field of medical science. The Nanomedicine Initiative applies an > engineering approach to the study of cellular and subcellular systems in > an effort not only to understand, but to precisely control molecular > complexes that operate at the nanoscale. This will allow for development > of new technologies to prevent or cure disease and to repair damaged > tissue ... " - The complete text of the news release is posted at > http://www.nih.gov/news/pr/oct2006/nei-27.htm - Information about the NIH > NDC program is posted at http://nihroadmap.nih.gov/nanomedicine/index.asp > - Information about the NIH Roadmap is posted at http://nihroadmap.nih.gov > > > http://www.nih.gov/news/pr/oct2006/nei-27.htm > > Date: Fri, 27 Oct 2006 10:08:09 -0400 > > > > Subject: NIH COMPLETES FORMATION OF NATIONAL NETWORK OF NANOMEDICINE > CENTERS > > Sender: NIH news releases and news items > > To: NIHPRESS@... > > U.S. Department of Health and Human Services > NATIONAL INSTITUTES OF HEALTH > NIH News > National Eye Institute (NEI) > < http://www.nei.nih.gov/> > > FOR IMMEDIATE RELEASE: Friday, October 27, 2006 > > CONTACT: National Eye Institute, > > NIH News Advisory > > NIH COMPLETES FORMATION OF NATIONAL NETWORK OF NANOMEDICINE CENTERS > > WHAT: The National Institutes of Health (NIH) has completed its > national network of eight Nanomedicine Development Centers (NDCs). > > WHY: To announce to the scientific community the completion of the > national network of NDCs. > > WHEN: The final four NDCs were funded this year. NIH funded four NDCs > last year. > > WHERE: The final four NDCs are located at: > > -- Georgia Institute of Technology in Atlanta > -- Purdue University in Lafayette, Indiana > -- University of California at Los Angeles > -- University of California Lawrence Berkeley National Laboratory > > The four NDCs funded last year are located at: > > -- Baylor College of Medicine in Houston > -- University of Illinois Urbana-Champaign > -- University of California at San Francisco > -- Columbia University, New York Morningside > > MORE INFORMATION: NDCs are staffed by multidisciplinary scientific > teams, including biologists, physicians, chemists, physicists, > mathematicians, engineers, and computer scientists. In addition to > conducting research into the physical properties of structures inside > cells to determine how biology's molecular machines are built, these > teams will begin training the next generation of students in this > emerging field of medical science. The Nanomedicine Initiative applies an > engineering approach to the study of cellular and subcellular systems in > an effort not only to understand, but to precisely control molecular > complexes that operate at the nanoscale. This will allow for development > of new technologies to prevent or cure disease and to repair damaged > tissue. > > The Nanomedicine Initiative, part of NIH's Roadmap for Medical Research, > is led by A. Sieving, M.D., Ph.D., director of the National Eye > Institute (NEI), Jeffery Schloss, Ph.D., program director, Technology > Development, National Human Genome Research Institute, and S. > Fisher, Ph.D., program director, Corneal Diseases at NEI, in > collaboration with a program team representing institutes and centers > across the NIH. " Future progress in medicine will depend on our > understanding and modulating the complexity of biological systems, " said > Dr. Sieving. " The NIH Roadmap, including the Nanomedicine Initiative, > will advance our knowledge of biological systems. This will provide the > scientific foundation for new strategies for diagnosing, treating, and > preventing disease. " > > For further information on this program, visit: < > http://nihroadmap.nih.gov/nanomedicine/index.asp> > > The NIH Roadmap for Medical Research is a series of far-reaching > initiatives designed to transform the Nation's medical research > capabilities and speed the movement of scientific discoveries from the > bench to the bedside. It provides a framework of the priorities the NIH > must address in order to optimize its entire research portfolio and lays > out a vision for a more efficient and productive system of medical > research. Additional information about the NIH Roadmap can be found at < > http://nihroadmap.nih.gov>. > > The National Eye Institute (NEI) is part of the National Institutes of > Health (NIH) and is the Federal government's lead agency for vision > research that leads to sight-saving treatments and plays a key role in > reducing visual impairment and blindness. For more information, visit the > NEI Website at < http://www.nei.nih.gov/>. > > The National Institutes of Health (NIH) -- The Nation's Medical Research > Agency -- includes 27 Institutes and Centers and is a component of the > U.S. Department of Health and Human Services. It is the primary federal > agency for conducting and supporting basic, clinical and translational > medical research, and it investigates the causes, treatments, and cures > for both common and rare diseases. For more information about NIH and its > programs, visit <www.nih.gov >. > > ## > > This NIH News Release is available online at: > http://www.nih.gov/news/pr/oct2006/nei-27.htm Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.